Literature DB >> 18802012

Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages.

Qi Hao1, Jianrong Liu, Rajita Pappu, Hua Su, Radoslaw Rola, Rodney A Gabriel, Chanhung Z Lee, William L Young, Guo-Yuan Yang.   

Abstract

OBJECTIVE: We investigated the role of bone marrow-derived cells (BMDCs) in an angiogenic focus, induced by VEGF stimulation. METHODS AND
RESULTS: BM from GFP donor mice was isolated and transplanted into lethally irradiated recipients. Four weeks after transplantation, groups of mice received adeno-associated viral vector (AAV)-VEGF or AAV-lacZ gene (control) injection and were euthanized at 1 to 24 weeks. BMDCs were characterized by double-labeled immunostaining. The function of BMDCs was further examined through matrix metalloproteinase (MMP)-2 and -9 activity. We found that capillary density increased after 2 weeks, peaked at 4 weeks (P<0.01), and sustained up to 24 weeks after gene transfer. GFP-positive BMDCs infiltration in the angiogenic focus began at 1 week, peaked at 2 weeks, and decreased thereafter. The GFP-positive BMDCs were colocalized with CD45 (94%), CD68 (71%), 5% Vimentin (5%), CD31/von Willebrand factor (vWF) (1%), and alpha-smooth muscle actin (alpha -SMA, 0.5%). Infiltrated BMDCs expressed MMP-9. MMP-9 KO mice confirmed the dependence of the angiogenic response on MMP-9 availability.
CONCLUSIONS: Nearly all BMDCs in the angiogenic focus showed expression for leukocytes/macrophages, indicating that BMDCs minimally incorporated into the neovasculature. Colocalization of MMPs with GFP suggests that BMDCs play a critical role in VEGF-induced angiogenic response through up-regulation of MMPs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802012      PMCID: PMC2610019          DOI: 10.1161/ATVBAHA.108.176297

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  42 in total

1.  Targeting of marrow-derived astrocytes to the ischemic brain.

Authors:  M A Eglitis; D Dawson; K W Park; M M Mouradian
Journal:  Neuroreport       Date:  1999-04-26       Impact factor: 1.837

Review 2.  Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis.

Authors:  T L Haas; J A Madri
Journal:  Trends Cardiovasc Med       Date:  1999 Apr-May       Impact factor: 6.677

3.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.

Authors:  G Bergers; R Brekken; G McMahon; T H Vu; T Itoh; K Tamaki; K Tanzawa; P Thorpe; S Itohara; Z Werb; D Hanahan
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

4.  MMP-12, an old enzyme plays a new role in the pathogenesis of rheumatoid arthritis?

Authors:  Yuqing E Chen
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

5.  The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.

Authors:  Sonata Jodele; Christophe F Chantrain; Laurence Blavier; Carolyn Lutzko; Gay M Crooks; Hiroyuki Shimada; Lisa M Coussens; Yves A Declerck
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.

Authors:  Z G Zhang; L Zhang; Q Jiang; R Zhang; K Davies; C Powers; N v Bruggen; M Chopp
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

Authors:  L M Coussens; C L Tinkle; D Hanahan; Z Werb
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

8.  Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia.

Authors:  T Hayashi; K Abe; Y Itoyama
Journal:  J Cereb Blood Flow Metab       Date:  1998-08       Impact factor: 6.200

9.  Evidence for circulating bone marrow-derived endothelial cells.

Authors:  Q Shi; S Rafii; M H Wu; E S Wijelath; C Yu; A Ishida; Y Fujita; S Kothari; R Mohle; L R Sauvage; M A Moore; R F Storb; W P Hammond
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

10.  Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model.

Authors:  Chanhung Z Lee; Bin Xu; Tomoki Hashimoto; Charles E McCulloch; Guo-Yuan Yang; William L Young
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

View more
  21 in total

1.  Involvement of natural killer T cells in halothane-induced liver injury in mice.

Authors:  Linling Cheng; Qiang You; Hao Yin; Michael P Holt; Cynthia Ju
Journal:  Biochem Pharmacol       Date:  2010-03-30       Impact factor: 5.858

2.  Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.

Authors:  Helen Kim; Hua Su; Shantel Weinsheimer; Ludmila Pawlikowska; William L Young
Journal:  Acta Neurochir Suppl       Date:  2011

3.  Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain arteriovenous malformation.

Authors:  Rui Zhang; Zhenying Han; Vincent Degos; Fanxia Shen; Eun-Jung Choi; Zhengda Sun; Shuai Kang; Michael Wong; Wan Zhu; Lei Zhan; Helen M Arthur; S Paul Oh; Marie E Faughnan; Hua Su
Journal:  Angiogenesis       Date:  2016-06-20       Impact factor: 9.596

Review 4.  Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.

Authors:  Rui Zhang; Wan Zhu; Hua Su
Journal:  Acta Neurochir Suppl       Date:  2016

5.  Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.

Authors:  Wan Zhu; Wanqiu Chen; Dingquan Zou; Liang Wang; Chen Bao; Lei Zhan; Daniel Saw; Sen Wang; Ethan Winkler; Zhengxi Li; Meng Zhang; Fanxia Shen; Sonali Shaligram; Michael Lawton; Hua Su
Journal:  Stroke       Date:  2018-03-28       Impact factor: 7.914

6.  Bone marrow-derived cells contribute to vascular endothelial growth factor-induced angiogenesis in the adult mouse brain by supplying matrix metalloproteinase-9.

Authors:  Qi Hao; Hua Su; Daniel Palmer; Baoliang Sun; Peng Gao; Guo-Yuan Yang; William L Young
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

7.  Nitric oxide in vascular endothelial growth factor-induced focal angiogenesis and matrix metalloproteinase-9 activity in the mouse brain.

Authors:  Chanhung Z Lee; Zheng Xue; Qi Hao; Guo-Yuan Yang; William L Young
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

8.  Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Yasuyuki Ohta; Makiko Nagai; Kazunori Miyazaki; Nobuhito Tanaka; Hiromi Kawai; Takafumi Mimoto; Nobutoshi Morimoto; Tomoko Kurata; Yoshio Ikeda; Tohru Matsuura; Koji Abe
Journal:  Cell Med       Date:  2011-10-01

Review 9.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

10.  Nonischemic cerebral venous hypertension promotes a pro-angiogenic stage through HIF-1 downstream genes and leukocyte-derived MMP-9.

Authors:  Peng Gao; Yiqian Zhu; Feng Ling; Fanxia Shen; Brian Lee; Rodney Allanigue Gabriel; Qi Hao; Guo-Yuan Yang; Hua Su; William L Young
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-27       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.